Increased resistance to 14 alpha-demethylase inhibitors (DMIs) in Aspergillus niger by coexpression of the Penicillium itulicum eburicol 14 alpha-demethylase (cyp51) and the A-niger cytochromeP450 reductase (cprA) genes

J.M. van den Brink, J.G.M. van Nistelrooy, M.A. de Waard, C.A.M.J.J. van den Hondel, R.F.M. van Gorcom

Research output: Contribution to journalArticleAcademicpeer-review

26 Citations (Scopus)

Abstract

In this paper we describe the effects of over-expression of the Penicillium italicum gene encoding eburicol 14α-demethylase (cyp51), in Aspergillus niger strains with one or multiple copies of the gene encoding cytochrome P450 reductase (cprA), on the eburicol 14α-demethylase activity. Eburicol 14α-demethylase activity was determined by measuring the resistance of transformants against some eburicol 14α-demethylase inhibitors (DMIs). DMIs are widely used as fungicides in crop protection and human and veterinarian health care. DMI resistance in a transformant overexpressing both CPR and CYP51 was increased 5–30-fold compared to DMI resistance in the wild type strain, depending on the test compound used. Resistance in this strain was approximately 2–5-fold increased compared to DMI resistance in a transformant that was overexpressing the cyp51 gene but had only the wild type copy of the cprA gene and approximately 3–12-fold increased compared to a strain overexpressing the cprA gene (and having only the wild type copy of the cyp51 gene). These results show the importance of CPR overexpression for increasing cytochrome P450 activities in filamentous fungi.
Original languageEnglish
Pages (from-to)13-18
JournalJournal of Biotechnology
Volume49
DOIs
Publication statusPublished - 1996

Fingerprint

Dive into the research topics of 'Increased resistance to 14 alpha-demethylase inhibitors (DMIs) in Aspergillus niger by coexpression of the Penicillium itulicum eburicol 14 alpha-demethylase (cyp51) and the A-niger cytochromeP450 reductase (cprA) genes'. Together they form a unique fingerprint.

Cite this